Pharmaceutical - Asia-Pacific, Dainippon Sumitomo Pharma


Popular Filters

Dainippon Sumitomo partners with Nippon Shinyaku for urology drug AMP-986


Japanese drugmakers Dainippon Sumitomo Pharma (TYO: 4506) and Nippon Shinyaku (TYO: 4516) have concluded…

AMP-986Asia-PacificDainippon Sumitomo PharmaGenito-urinaryLicensingNippon ShinyakuPharmaceutical

Dainippon Sumitomo sets up subsidiary in Singapore


Japanese drug major Dainippon Sumitomo Pharma (TYO: 4506) has established a wholly-owned subsidiary in…

Asia-PacificDainippon Sumitomo PharmaMarkets & MarketingPharmaceuticalSunovion

Japanese approvals for Eylea, Tresiba, Seebri and Aimix


There was a flurry of announcements from Japan's Ministry of Health, Labor and Welfare (MHLW) on Friday,…

AimixAsia-PacificBayerCardio-vascularDainippon Sumitomo PharmaDiabetesEyleaNovartisNovo NordiskOphthalmicsPharmaceuticalRegeneronRegulationRespiratory and PulmonarySeebri BreezhalerShionogiTresibaVectura

Dainippon Sumitomo files for approval of Calsed in China


Japanese drug major Dainippon Sumitomo Pharma (TYO: 4506) has submitted an imported drug registration…

Asia-PacificCalsedDainippon Sumitomo PharmaOncologyPharmaceuticalRegulation

Dainippon Sumitomo Pharma and Shionogi to co-market antihypertensive DSP-8153


Dainippon Sumitomo Pharma (DSP; TYO: 4506) has entered into a license accord with fellow Japanese drugmaker…

Amlodipine BesylateAsia-PacificCardio-vascularDainippon Sumitomo PharmaDSP-8153irbesartanLicensingMarkets & MarketingPharmaceuticalShionogi

Back to top